Table 2 Mean circulating IL-6 across IL-6 gene -174G/C genotypes in this meta-analysis.
From: Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization
Author (year) | Ethnicity | Status | Sample size | Circulating IL-6 (pg/mL) across -174G/C genotypes | |||||
|---|---|---|---|---|---|---|---|---|---|
Mean (GG) | SD (GG) | Mean (GC) | SD (GC) | Mean (CC) | SD (CC) | ||||
Malaponte (2013) | Caucasian | Cancer patients | 130 | 22.10 | 4.30 | 11.90 | 2.60 | 5.30 | 1.50 |
Malaponte (2013) | Caucasian | Cancer patients | 190 | 7.20 | 2.20 | 12.00 | 1.70 | 4.50 | 1.10 |
Malaponte (2013) | Caucasian | Healthy controls | 215 | 2.80 | 0.70 | 2.70 | 0.50 | 2.60 | 0.70 |
Giannitrapani (2011) | Caucasian | Cancer patients | 67 | 2.20 | 2.86 | 2.30 | 1.70 | 2.90 | 0.60 |
Giannitrapani (2011) | Caucasian | Cancer patients | 80 | 4.80 | 4.25 | 3.60 | 3.00 | 0.87 | 1.97 |
Ognjanovic (2010) | Mixed | Cancer patients and controls | 806 | 1.90 | 0.05 | 2.23 | 2.69 | 2.35 | 1.91 |
Talar-Wojnarowska (2009) | Caucasian | Cancer patients | 97 | 65.00 | 10.00 | 27.00 | 10.00 | 33.00 | 10.00 |
Berkovic (2007) | Caucasian | Cancer patients | 80 | 3.07 | 1.03 | 4.31 | 2.98 | 7.51 | 4.33 |
Belluco (2003) | Caucasian | Cancer patients | 62 | 0.32 | 0.62 | 0.14 | 0.13 | 0.14 | 0.13 |
